Brentuximab, a chimeric antibody targeting CD30, is a naked antibody to Brentuximab vedotin. It possesses antitumor activity and may be used to study relapsed or refractory Hodgkins lymphoma.
Purity:
94.60%
CAS Number:
[2088770-90-3]
Target:
ADC Antibody|||TNF
T76718
T76718
* VAT and and shipping costs not included. Errors and price changes excepted
